|
Market Closed -
Hong Kong S.E.
07:08:09 23/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 4.870 HKD | +3.62% |
|
+3.73% | -7.59% |
| 09/10 | GF Securities Starts CStone Pharmaceuticals at Buy with HK$11.56 Price Target | MT |
| 24/09 | CStone Pharma CEO Buys HK$2.7 Million of Shares | MT |
Company Valuation: CStone Pharmaceuticals
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,845 | 4,882 | 2,628 | 2,759 | 6,980 | 6,593 | - | - |
| Change | - | -37.77% | -46.18% | 4.99% | 153.01% | -5.55% | - | - |
| Enterprise Value (EV) 1 | 7,249 | 4,551 | 1,950 | 2,404 | 6,404 | 5,615 | 2,570 | 2,421 |
| Change | - | -37.22% | -57.15% | 23.28% | 166.37% | -12.32% | -54.23% | -5.8% |
| P/E | - | -5.32x | -7.11x | -30.9x | -15.3x | -14.3x | 3.87x | 29.6x |
| PBR | 6.63x | 10.9x | 5.7x | - | 10.7x | - | - | - |
| PEG | - | - | 0.1x | 0.4x | -0x | 2.22x | -0x | -0.3x |
| Capitalization / Revenue | 32.2x | 10.1x | 5.67x | 6.78x | 25.9x | 15.6x | 3.83x | 6.89x |
| EV / Revenue | 29.7x | 9.45x | 4.2x | 5.9x | 23.8x | 13.3x | 1.49x | 2.53x |
| EV / EBITDA | -3.99x | -5.1x | -3.33x | -25.9x | -16.5x | -13.9x | 1.33x | 11.4x |
| EV / EBIT | -3.96x | -4.99x | -3.22x | -22.7x | -14.8x | -14.7x | 2.33x | -30.8x |
| EV / FCF | -4.57x | -7.43x | - | - | -19.5x | -17.9x | -13x | -19.7x |
| FCF Yield | -21.9% | -13.5% | - | - | -5.12% | -5.59% | -7.7% | -5.08% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | -0.77 | -0.29 | -0.07 | -0.31 | -0.29 | 1.07 | 0.14 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 243.7 | 481.4 | 463.8 | 407.2 | 269.6 | 423.2 | 1,722 | 956.2 |
| EBITDA 1 | -1,818 | -892.9 | -585.4 | -92.72 | -388.6 | -405.2 | 1,937 | 212.3 |
| EBIT 1 | -1,829 | -912.1 | -605.6 | -106.1 | -432.6 | -381 | 1,102 | -78.51 |
| Net income 1 | -1,920 | -902.7 | -367.2 | -91.21 | -437 | -383.5 | 680.5 | -48.57 |
| Net Debt 1 | -596.2 | -331.1 | -677.7 | -354.7 | -576.3 | -977.7 | -4,023 | -4,172 |
| Reference price 2 | 6.737 | 4.096 | 2.061 | 2.161 | 4.736 | 4.142 | 4.142 | 4.142 |
| Nbr of stocks (in thousands) | 1,164,452 | 1,192,099 | 1,275,317 | 1,276,503 | 1,473,942 | 1,591,633 | - | - |
| Announcement Date | 8/6/22 | 26/4/23 | 23/4/24 | 27/3/25 | 26/3/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.81x | 12.75x | -13.32x | -.--% | 955M | |
| 37.7x | 13.43x | 28.51x | 0.52% | 1,165B | |
| 39.17x | 6.59x | 18.54x | 1.99% | 645B | |
| 36.4x | 8.37x | 17.27x | 2.41% | 504B | |
| 20.97x | 5.15x | 12.78x | 2.55% | 380B | |
| 107.33x | 5.99x | 25.72x | 2.31% | 363B | |
| 21.95x | 5.71x | 14.04x | 2.79% | 297B | |
| 22.67x | 4.58x | 13.09x | 1.93% | 269B | |
| 28.38x | 7.14x | 12.79x | 2.26% | 237B | |
| -45.82x | 7.02x | 27.23x | 2.1% | 195B | |
| Average | 25.49x | 7.67x | 15.67x | 1.89% | 405.64B | |
| Weighted average by Cap. | 35.72x | 8.44x | 20.73x | 1.78% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 2616 Stock
- Valuation CStone Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
